Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action ; day:7 ; month:3 ; year:2024 ; pages:1-4
Molecular psychiatry ; (7.3.2024), 1-4
- Urheber
-
Allott, Kelly
Chopra, Sidhant
Rogers, Jack
Dauvermann, Maria Regina
Clark, Scott Richard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02503-x
- URN
-
urn:nbn:de:101:1-2405102104578.078049187405
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Allott, Kelly
- Chopra, Sidhant
- Rogers, Jack
- Dauvermann, Maria Regina
- Clark, Scott Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
The role of pharmacists in supporting service users to optimise antipsychotic medication
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
The role of pharmacists in supporting service users to optimise antipsychotic medication
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
The role of pharmacists in supporting service users to optimise antipsychotic medication